Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19903558 | 0.91 | RXRA (0.33) | MAPTXBP1HTTALDH1A1GLA | |
| SCHEMBL19912548 | 0.90 | MAPT (0.32) | MAPTXBP1HTTALDH1A1GLA | |
| SCHEMBL19903557 | 0.90 | RXRA (0.34) | MAPTXBP1HTTALDH1A1GLA | |
| SCHEMBL19912551 | 0.89 | MAPT (0.33) | MAPTXBP1HTTALDH1A1GLA | |
| SCHEMBL19903553 | 0.89 | KIF11 (0.34) | MAPTXBP1HTTALDH1A1 | |
| SCHEMBL20617439 | 0.88 | RXRA (0.39) | MAPTXBP1HTT | |
| SCHEMBL19912558 | 0.88 | KIF11 (0.34) | MAPTALDH1A1 | |
| SCHEMBL23348227 | 0.87 | KCNJ5 (0.32) | — | |
| SCHEMBL19903554 | 0.87 | PDE9A (0.34) | MAPTXBP1HTTALDH1A1HPGD | |
| SCHEMBL20617433 | 0.87 | RXRA (0.40) | MAPTXBP1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CCND2, CCND1, CRY1 | MAPT 1531/4885XBP1 2764/4885HTT 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.